REFERENCES
- Ortiz de Montellano P.R. Cytochrome P450. 2nd Ed., Plenum, New York 1995
- Ioannides C. Cytochromes P450: Metabolic and Toxicological Aspects. CRC Press, Boca Raton, Florida 1996
- Lewis D.F.V. Cytochromes P450: Structure, Function and Mechanism. Taylor and Francis, London 1996
- Lewis D.F.V. Guide to Cytochromes P450 Structure and Function. Taylor and Francis, London 2001
- Rendic S., DiCarlo F.J. Human Cytochrome P450 Enzymes: a Status Report Summarizing their Reactions, Substrates, Inducers and Inhibitors. Drug Metab. Rev. 1997; 29: 413–580
- Lewis D.F.V., Lake B.G., George S.G., Dickins M., Eddershaw P.J., Tarbit M.H., Beresford A.P., Goldfarb P.S., Guengerich F.P. Molecular Modeling of CYP1 Family Enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 Based on Sequence Homology with CYP102. Toxicology 1999; 139: 53–79
- Lewis D.F.V., Dickins M., Lake B.G., Eddershaw P.J., Tarbit M.H., Goldfarb P.S. Molecular Modeling of the Human Cytochrome P450 Isoform CYP2A6 and Investigations of CYP2A Substrate Selectivity. Toxicology 1999; 133: 1–33
- Lewis D.F.V., Lake B.G., Dickins M., Eddershaw P.J., Tarbit M.H., Goldfarb P.S. Molecular Modeling of CYP2B6, the Human CYP2B Isoform, by Homology with the Substrate-Bound CYP102 Crystal Structure: Evaluation of CYP2B6 Substrate Characteristics, the Cytochrome b5 Binding Site and Comparisons with CYP2B1 and CYP2B4. Xenobiotica 1999; 29: 361–393
- Lewis D.F.V., Dickins M., Weaver R.J., Eddershaw P.J., Goldfarb P.S., Tarbit M.H. Molecular Modeling of Human CYP2C Enzymes CYP2C9 and CYP2C19: Rationalization of Substrate Specificity and Site-Directed Mutagenesis Experiments in the CYP2C Subfamily. Xenobiotica 1998; 28: 235–268
- Lewis D.F.V., Eddershaw P.J., Goldfarb P.S., Tarbit M.H. Molecular Modeling of Cytochrome P4502D6 (CYP2D6) Based on an Alignment with CYP102: Structural Studies on Specific CYP2D6 Substrate Metabolism. Xenobiotica 1997; 27: 319–340
- Lewis D.F.V., Bird M.G., Dickins M., Lake B.G., Eddershaw P.J., Tarbit M.H., Goldfarb P.S. Molecular Modeling of Human CYP2E1 by Homology with the CYP102 Haemoprotein Domain: Investigation of the Interactions of Substrates and Inhibitors Within the Putative Active Site of the Human CYP2E1 Isoform. Xenobiotica 2000; 30: 1–25
- Lewis D.F.V., Eddershaw P.J., Goldfarb P.S., Tarbit M.H. Molecular Modeling of CYP3A4 From an Alignment with CYP102: Identification of Key Interactions Between Putative Active Site Residues and CYP3A-Specific Chemicals. Xenobiotica 1996; 26: 1067–1086
- Lewis D.F.V., Lake B.G. Molecular Modeling of CYP4A Subfamily Members Based on Sequence Homology with CYP102. Xenobiotica 1999; 29: 763–781
- Lewis D.F.V. The CYP2 Family: Models, Mutants and Interactions. Xenobiotica 1998; 28: 617–661
- Lewis D.F.V. Molecular Modeling of Human Cytochromes P450 Involved in Xenobiotic Metabolism and Rationalization of Substrate Specificity. Exper. Toxicol. Pathol. 1999; 51: 369–374
- Lewis D.F.V. Modeling Human Cytochromes P450 for Evaluating Drug Metabolism: an Update. Drug Metab. Drug Interact. 2000; 16: 307–324
- Lewis D.F.V. On the Recognition of Mammalian Microsomal Cytochrome P450 Substrates and Their Characteristics. Biochem. Pharmacol. 2000; 60: 293–306
- Lewis D.F.V., Dickins M., Eddershaw P.J., Tarbit M.H., Goldfarb P.S. Cytochrome P450 Substrate Specificites, Substrate Templates and Enzyme Active Site Geometries. Drug Metab. Drug Interact. 1999; 15: 1–49
- Lewis D.F.V., Eddershaw P.J., Dickins M., Tarbit M.H., Goldfarb P.S. Structural Determinants of P450 Substrate Specificity, Binding Affinity and Catalytic Rate. Chemico-Biol. Interact. 1998; 115: 175–199
- Lewis D.F.V., Pratt J.M. The Cytochrome P450 Catalytic Cycle and Mechanism of Oxygenation. Drug Metab. Rev. 1998; 30: 739–786
- Lewis D.F.V., Hlavica P. Interactions Between Redox Partners in Various Cytochrome P450 Systems: Functional and Structural Aspects. Biochim. Biophys. Acta 2000; 1460: 353–374
- Lewis D.F.V. Structural Characteristics of Human P450s Involved in Drug Metabolism: QSARs and Lipophilicity Profiles. Toxicology 2000; 144: 197–203